BioVersys AG | WebDisclosure

BRIEF

published on 03/26/2025 at 07:05, 2 months 4 days ago

BioVersys Outlines 2024 Achievements and Financials

2024 Financials IPO Success BioVersys AG BV100 Trial Alpibectir Studies
PRESS RELEASE

published on 03/26/2025 at 07:00, 2 months 4 days ago

BIOVERSYS REPORTS CORPORATE HIGHLIGHS AND KEY FINANCIALS FOR THE FULL YEAR 2024
BioVersys AG reports corporate highlights and key financials for the full year 2024 including successful IPO on SIX Swiss Exchange, Phase 2 trial results, and financial activities

Financial Results Clinical Trials IPO Operating Income BioVersys AG
BRIEF

published on 03/19/2025 at 07:05, 2 months 11 days ago

Premier patient traité dans le cadre de l'essai Alpibectir-Éthionamide contre la tuberculose

Essai De Phase 2 Collaboration GSK BioVersys Alpibectir-Ethionamide Tuberculose
BRIEF

published on 03/19/2025 at 07:05, 2 months 11 days ago

First Patient Dosed in Alpibectir-Ethionamide TB Trial

Phase 2 Trial GSK Collaboration BioVersys Alpibectir-Ethionamide Tuberculosis
PRESS RELEASE

published on 03/19/2025 at 07:00, 2 months 11 days ago

FIRST EVER PATIENT DOSED WITH ALPIBECTIR-ETHIONAMIDE IN COMBINATION WITH FIRST-LINE TB DRUGS IN A 14-DAY PHASE 2 CLINICAL TRIAL
First patient dosed in 14-day Phase 2 clinical trial evaluating Alpibectir-Ethionamide with first-line TB drugs under BioVersys and GSK collaboration for pulmonary TB patients

GSK Phase 2 BioVersys Alpibectir-Ethionamide TB
BRIEF

published on 03/14/2025 at 07:05, 2 months 16 days ago

BioVersys annonce la publication de ses résultats financiers pour l'exercice 2024 au 26 mars

Résultats Financiers Biopharmaceutique Conférence Téléphonique Produits Antibactériens BioVersys
BRIEF

published on 03/14/2025 at 07:05, 2 months 16 days ago

BioVersys Sets March 26 for Full-Year 2024 Financial Results Release

Financial Results Conference Call Biopharmaceutical Antibacterial Products BioVersys
PRESS RELEASE

published on 03/14/2025 at 07:00, 2 months 16 days ago

BIOVERSYS ANNOUNCES REPORTING DATE FOR FULL-YEAR 2024 FINANCIAL RESULTS AND EVENT DETAILS
BioVersys AG announces reporting date for full-year 2024 financial results and event details, including a conference call and webcast on March 26, 2025. The company focuses on developing novel antibacterial products for MDR bacteria

Financial Results Conference Call BioVersys AG Antibacterial Products MDR Bacteria
BRIEF

published on 03/10/2025 at 07:05, 2 months 20 days ago

BioVersys AG annonce l'exercice partiel de son option de surallocation

Bourse Suisse SIX Option De Surallocation Entreprise Biopharmaceutique Introduction En Bourse De BioVersys Produits Antibactériens
BRIEF

published on 03/10/2025 at 07:05, 2 months 20 days ago

BioVersys AG Announces Partial Exercise of Over-Allotment Option

Biopharmaceutical Company SIX Swiss Exchange Over-allotment Option BioVersys IPO Antibacterial Products

Published on 05/30/2025 at 23:10, 32 minutes ago

CORRECTION: Nextech3D.ai Migrates MAP Dynamics to AWS, Enabling Scalable AI Architecture and Accelerated Deployment
Published on 05/30/2025 at 23:00, 42 minutes ago

Battery X Metals Achieves Full Capacity Recovery on a Real-World Imbalanced Battery from the #2 Out-of-Warranty Electric Vehicle Model in the United States in Preliminary Trial
Published on 05/30/2025 at 22:30, 1 hour 12 minutes ago

Pinetree Capital Ltd Announces Election of Directors
Published on 05/30/2025 at 22:15, 1 hour 27 minutes ago

Banyan Files Amended Technical Report on AurMac and Provides an Update on Hyland
Published on 05/30/2025 at 22:00, 1 hour 42 minutes ago

Jaguar Mining Announces Management Changes to Support Next Phase of Growth

View all ACCESSWIRE

Published on 05/30/2025 at 21:22, 2 hours 20 minutes ago

CPI PROPERTY GROUP publishes financial results for the first quarter of 2025
Published on 05/30/2025 at 20:30, 3 hours 12 minutes ago

IUTE GROUP ISSUES EUR 140 MILLION NEW SENIOR SECURED EUR 2025/2030 BONDS – Strong demand from existing investors and new subscriptions
Published on 05/30/2025 at 18:05, 5 hours 37 minutes ago

Eurobattery Minerals will submit additional documentation for the EPA at the end of June
Published on 05/30/2025 at 18:04, 5 hours 38 minutes ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 05/30/2025 at 18:00, 5 hours 42 minutes ago

XTransfer participera pour la première fois en tant que sponsor 4 étoiles au salon Money20/20 Europe 2025

View all EQS

Published on 05/30/2025 at 22:00, 1 hour 42 minutes ago

Information sur les comptes annuels
Published on 05/30/2025 at 22:00, 1 hour 42 minutes ago

Information on the Annual Financial Statements
Published on 05/30/2025 at 18:14, 5 hours 27 minutes ago

Emova Group - Rapport annuel de Durabilité 23/24
Published on 05/28/2025 at 23:00, 2 days ago

Standstill Commitments to hold shares of the company
Published on 05/28/2025 at 23:00, 2 days ago

Engagements collectifs de conservation de titres de la société

View all LES ECHOS COMFI WIRE

News